Dawnrays Pharmaceutical Holdings Ltd. Annual Results: Standalone & Consolidated Reports

Annual Results

Results Snapshot

Figures in Million

Consolidate Annual Results

Dec'23

Dec'22

Dec'21

Dec'20

Dec'19

Dec'18

Dec'17

Net Sales

1,272.01

1,485.79

1,404.26

1,150.97

1,077.23

1,123.97

1,017.58

Other Operating Income

0.00

Total Operating income

1,272.01

1,485.79

1,404.26

1,150.97

1,077.23

1,123.97

1,017.58

Raw Material Cost

573.75

613.83

605.99

552.12

487.24

432.22

381.91

Purchase of Finished goods

0.00

(Increase) / Decrease In Stocks

0.00

Employee Cost

234.02

210.51

195.67

163.44

148.41

150.31

139.08

Power Cost

0.00

Manufacturing Expenses

1.09

0.43

0.77

5.43

6.02

1.36

0.01

Selling and Distribution Expenses

284.57

288.60

254.20

166.94

136.31

157.93

144.80

Other Expenses

-14.16

-12.40

-11.98

-10.65

-10.01

-9.73

-9.85

Total Expenditure (Excl Depreciation)

951.82

989.42

936.88

781.38

677.85

644.56

567.29

Operating Profit (PBDIT) excl Other Income

320.20000000000005

496.4

467.40000000000003

369.6

399.4

479.4

450.3

Other Income

191.13

85.07

119.23

24.08

-19.09

-8.48

-30.29

Operating Profit (PBDIT)

575.27

651.07

648.85

454.90

443.14

533.80

480.71

Interest

1.09

0.43

0.77

5.43

6.02

1.36

0.01

Exceptional Items

6.27

8.39

6.70

10.85

-4.70

-7.18

1.70

Gross Profit (PBDT)

698.26

871.95

798.26

598.85

589.99

691.75

635.67

Depreciation

78.35

77.23

69.35

66.95

62.85

61.15

60.70

Profit Before Tax

502.76

581.80

585.42

393.37

369.57

464.10

421.69

Tax

100.99

96.00

102.64

74.73

66.60

87.43

83.86

Provisions and contingencies

0.00

Profit After Tax

360.23

416.38

431.68

301.30

289.64

360.03

337.83

Extraordinary Items

0.00

Prior Period Expenses

0.00

Other Adjustments

0.00

Net Profit

360.23

416.38

431.68

301.30

289.64

360.03

337.83

Share in Profit of Associates

0.00

Minority Interest

-3.68

-2.57

-4.84

-3.75

-0.08

0.00

Other related items

0.00

Consolidated Net Profit

356.55

413.81

426.84

297.55

289.55

360.03

337.83

Equity Capital

0.00

Face Value

0.0

0.06

0.0

Reserves

3,142.99

2,966.23

2,912.25

2,573.44

2,265.87

2,190.81

2,168.19

Earnings per share (EPS)

0.24

0.28

0.29

0.19

0.18

0.23

0.21

Diluted Earnings per share

0.24

0.28

0.29

0.19

0.18

0.23

0.21

Operating Profit Margin (Excl OI)

24.04%

32.9%

32.78%

31.61%

37.07%

42.81%

44.25%

Gross Profit Margin

45.68%

44.36%

46.63%

39.99%

40.14%

46.73%

47.41%

PAT Margin

28.32%

28.02%

30.74%

26.18%

26.89%

32.03%

33.2%

Public Share Holdings (%)

0.0%

Pledged Promotor Holding (%)

0.0%

Annual Analysis Highlights

Net Sales

YoY Growth in year ended Dec 2023 is -14.39% vs 5.80% in Dec 2022

Consolidate Net Profit

YoY Growth in year ended Dec 2023 is -13.85% vs -3.05% in Dec 2022

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Dec 2023 is -32.14% vs 6.87% in Dec 2022

Interest

YoY Growth in year ended Dec 2023 is 175.00% vs -50.00% in Dec 2022

Operating Profit Margin (Excl OI)

YoY Growth in year ended Dec 2023 has fallen from Dec 2022

Compare Annual Results Of Dawnrays Pharmaceutical Holdings Ltd. With

Select Peers

Figures in Million

Consolidate Annual Results

Change(HKD)

Change(%)

Net Sales

1,272.01

6,206.58

-4,934.57

-79.51%

Other Operating Income

0.00

Total Operating income

1,272.01

6,206.58

-4,934.57

-79.51%

Raw Material Cost

573.75

1,731.39

-1,157.64

-66.86%

Purchase of Finished goods

0.00

(Increase) / Decrease In Stocks

0.00

Employee Cost

234.02

1,795.66

-1,561.64

-86.97%

Power Cost

0.00

Manufacturing Expenses

1.09

133.24

-132.15

-99.18%

Selling and Distribution Expenses

284.57

2,475.80

-2,191.23

-88.51%

Other Expenses

-14.16

-86.85

72.69

83.70%

Total Expenditure (Excl Depreciation)

951.82

5,267.59

-4,315.77

-81.93%

Operating Profit (PBDIT) excl Other Income

320.20

939.00

-618.80

-65.90%

Other Income

191.13

111.36

79.77

71.63%

Operating Profit (PBDIT)

575.27

1,456.73

-881.46

-60.51%

Interest

1.09

133.24

-132.15

-99.18%

Exceptional Items

6.27

0.00

6.27

Gross Profit (PBDT)

698.26

4,475.19

-3,776.93

-84.40%

Depreciation

78.35

406.37

-328.02

-80.72%

Profit Before Tax

502.76

917.12

-414.36

-45.18%

Tax

100.99

27.55

73.44

266.57%

Provisions and contingencies

0.00

Profit After Tax

360.23

889.57

-529.34

-59.51%

Extraordinary Items

0.00

Prior Period Expenses

0.00

Other Adjustments

0.00

Net Profit

360.23

889.57

-529.34

-59.51%

Share in Profit of Associates

0.00

Minority Interest

-3.68

0.00

-3.68

Other related items

0.00

Consolidated Net Profit

356.55

889.57

-533.02

-59.92%

Equity Capital

0.00

Face Value

0.00

1.06

0.00

Reserves

3,142.99

3,207.13

-64.14

-2.00%

Earnings per share (EPS)

0.24

1.64

-1.40

-85.37%

Diluted Earnings per share

0.24

1.64

-1.40

-85.37%

Operating Profit Margin (Excl OI)

24.04%

15.13%

0.00

8.91%

Gross Profit Margin

45.68%

21.32%

0.00

24.36%

PAT Margin

28.32%

14.33%

0.00

13.99%

Public Share Holdings (%)

0.00

0.00%

Pledged Promotor Holding (%)

0.00

0.00%

Annual - Net Sales

Net Sales 127.20 Million

in Dec 2023

Figures in Million

YoY Growth in year ended Dec 2023 is -14.39% vs 5.80% in Dec 2022

Annual - Consolidate Net Profit

Consolidate Net Profit 35.65 Million

in Dec 2023

Figures in Million

YoY Growth in year ended Dec 2023 is -13.85% vs -3.05% in Dec 2022

Annual - Operating Profit (PBDIT)

Operating Profit (PBDIT) 38.41 Million

in Dec 2023

Figures in Million

YoY Growth in year ended Dec 2023 is -32.14% vs 6.87% in Dec 2022

Annual - Interest

Interest 0.11 Million

in Dec 2023

Figures in Million

YoY Growth in year ended Dec 2023 is 175.00% vs -50.00% in Dec 2022

Annual - Operating Profit Margin (Excl OI)

Operating Profit Margin (Excl OI) 24.04%

in Dec 2023

Figures in %

YoY Growth in year ended Dec 2023 has fallen from Dec 2022